These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33763471)

  • 1. Investigation of Hypoglycemic Peptides Derived from Conserved Regions of adMc1 to Reveal Their Antidiabetic Activities.
    Mahrosh HS; Mehmood R; Bukhari SA; Afzal G; Arif R
    Biomed Res Int; 2021; 2021():5550180. PubMed ID: 33763471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of
    Arif R; Ahmad S; Mustafa G; Mahrosh HS; Ali M; Tahir Ul Qamar M; Dar HR
    Biomed Res Int; 2021; 2021():5561129. PubMed ID: 34589547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the antihyperglycemic potential of tetrapeptides devised from AdMc1
    Mustafa G; Mahrosh HS; Zafar M; Attique SA; Arif R
    Int J Immunopathol Pharmacol; 2022; 36():3946320221103120. PubMed ID: 35574607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief review.
    Turdu G; Gao H; Jiang Y; Kabas M
    Future Med Chem; 2018 May; 10(10):1229-1239. PubMed ID: 29749760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
    Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes.
    Deacon CF
    Peptides; 2018 Feb; 100():150-157. PubMed ID: 29412814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Screening for the Dipeptidyl Peptidase-IV Inhibitory Peptides from Putative Hemp Seed Hydrolyzed Peptidome as a Potential Antidiabetic Agent.
    Thongtak A; Yutisayanuwat K; Harnkit N; Noikaew T; Chumnanpuen P
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
    Meduru H; Wang YT; Tsai JJ; Chen YC
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
    Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
    J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of peptides with antioxidant activity and antidiabetic potential obtained from chickpea (Cicer arietinum L.) protein hydrolyzates.
    Quintero-Soto MF; Chávez-Ontiveros J; Garzón-Tiznado JA; Salazar-Salas NY; Pineda-Hidalgo KV; Delgado-Vargas F; López-Valenzuela JA
    J Food Sci; 2021 Jul; 86(7):2962-2977. PubMed ID: 34076269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic peptide-enriched hydrolysates of Corbicula fluminea and Chlorella sorokiniana possess synergistic hypoglycemic activity through inhibiting α-glucosidase and dipeptidyl peptidase-4 activity.
    Huang TH; Liu PY; Lin YL; Tsai JS
    J Sci Food Agric; 2022 Jan; 102(2):716-723. PubMed ID: 34171123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination.
    Perumal N; Nallappan M; Shohaimi S; Kassim NK; Tee TT; Cheah YH
    Biomed Pharmacother; 2022 Jan; 145():112401. PubMed ID: 34785415
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Martins MCMR; Pantaleao SQ; de Oliveira Almeida M; Weber KC; Honorio KM
    Med Chem; 2021; 17(3):247-263. PubMed ID: 31995015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of in vitro angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitory peptides from draft beer by virtual screening and molecular docking.
    Wenhui T; Shumin H; Yongliang Z; Liping S; Hua Y
    J Sci Food Agric; 2022 Feb; 102(3):1085-1094. PubMed ID: 34309842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides Derived from Soy and Lupin Protein as Dipeptidyl-Peptidase IV Inhibitors: In Vitro Biochemical Screening and in Silico Molecular Modeling Study.
    Lammi C; Zanoni C; Arnoldi A; Vistoli G
    J Agric Food Chem; 2016 Dec; 64(51):9601-9606. PubMed ID: 27983830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple roles of food-derived bioactive peptides in the management of T2DM and commercial solutions: A review.
    Fan S; Liu Q; Du Q; Zeng X; Wu Z; Pan D; Tu M
    Int J Biol Macromol; 2024 Nov; 279(Pt 1):134993. PubMed ID: 39181375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses.
    Mohanty IR; Borde M; Kumar C S; Maheshwari U
    Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis.
    Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J
    Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening, discovery, and characterization of angiotensin-I converting enzyme inhibitory peptides derived from proteolytic hydrolysate of bitter melon seed proteins.
    Priyanto AD; Doerksen RJ; Chang CI; Sung WC; Widjanarko SB; Kusnadi J; Lin YC; Wang TC; Hsu JL
    J Proteomics; 2015 Oct; 128():424-35. PubMed ID: 26344130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.
    Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S
    Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.